Intuitive Surgical Inc.
NASDAQ · ISRGAs part of Intuitive’s mission, we believe that minimally invasive care is life-enhancing care. By combining ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints. We envision a future of care that is less invasive and profoundly better, where diseases are identified early and treated quickly so patients can get back to what matters most. Since our founding over 30 years ago, we have been delivering on this mission and vision by combining innovative technology with clinical expertise to advance minimally invasive care. We do so by providing a comprehensive ecosystem that includes robotic-assisted systems, instruments and accessories, customer learning, and customer support services all connected by a digital portfolio that enables actionable insights across the care continuum. Among other capabilities, these products and services can augment the skills and improve the efficiency of clinicians and care teams while providing decision support and learning that can help deliver differentiated clinical and economic value for patients, providers, and payers when compared to the next best available treatment options. To assure continued al
From the 10-K filed Feb 3, 2026
as of Oct 22, 2026 · today 432.01, 38% of the way from low to high
No dividends on record.
A company that pays none, or whose history has not arrived yet, shows nothing here.
Valuation
Results, trailing twelve months
Balance and cash
Shares and market
Financial statements
Total revenue +20.5% $8.35B → $10.06B, year ended Dec 31, 2025
Comps
Valuation, growth and margins against the closest competitors
Filings
10-K filed Feb 3, 2026 · 10-Q Oct 21, 2026
| Filing | Filed |
|---|---|
| 10-Q for Quarter Ended September 2026 | Oct 21, 2026 |
| 10-Q for Quarter Ended June 2026 | Jul 21, 2026 |
| 10-Q for Quarter Ended March 2026 | Apr 22, 2026 |
| 10-K for Fiscal Year Ended December 2025 | Feb 3, 2026 |
Insiders
$66.62M sold open market, 12 months to Oct 28, 2026
| Insider | Type | Value |
|---|---|---|
| Mark BrosiusOct 28, 2026 | Sale | $26.94K ↗ |
| Mark BrosiusOct 27, 2026 | Sale | $27.55K ↗ |
| Mark BrosiusOct 26, 2026 | Sale | $27.56K ↗ |
| Gary S GuthartOct 23, 2026 | Sale | $9.08M ↗ |
Funds (13F)
87.2% held by 2,296 managers · as of Sep 30, 2026
| Manager | Value | Change |
|---|---|---|
| BlackRock, Inc. | $11.94B | −51.26K (−0.2%) |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.20B | +51.61K (+0.2%) |
| STATE STREET CORP | $6.39B | +216.07K (+1.4%) |
| Invesco Ltd. | $4.71B | +653.08K (+5.8%) |
| PRICE T ROWE ASSOCIATES INC /MD/ | $4.48B | −1.26M (−10.1%) |
Congress
30 trades 12 sales · 18 purchases · 5 members, 12 months
| Member | Type | Amount |
|---|---|---|
| Ro KhannaSep 25, 2026 | Purchase | $1K–$15K |
| Ro KhannaSep 11, 2026 | Purchase | $1K–$15K |
| Ro KhannaSep 4, 2026 | Purchase | $1K–$15K |
| Ro KhannaAug 24, 2026 | Purchase | $1K–$15K |
Short interest
2.13% of float · 4.05 days to cover · Oct 15, 2026
Short position, last two years · 81% of its 2-year range
Source: FINRA
In the press
| Headline | Source | Published |
|---|---|---|
| Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing. ↗ | fool.com | Nov 1, 2026 |
| Intuitive Surgical: 3 Key Takeaways for Long-Term Investors ↗ | fool.com | Oct 21, 2026 |
| Intuitive Surgical (ISRG) Q3 2026 Earnings Call Transcript ↗ | fool.com | Oct 21, 2026 |
| Intuitive Surgical Stock Tumbles After Robotic Surgery Behemoth Narrows 2026 Outlook ↗ | investors.com | Oct 20, 2026 |
| 3 Wall Street Analysts See Intuitive Surgical Hitting $500. Here's the Bull Case. ↗ | fool.com | Oct 19, 2026 |
| Intuitive Surgical (ISRG) Stock Is Down 25% Year to Date. History Says Patient Investors Get Rewarded. ↗ | fool.com | Oct 17, 2026 |
| Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? ↗ | fool.com | Oct 12, 2026 |
Headlines indexed by The GDELT Project ↗, matched by company name, so one may be about something else. Each opens on its publisher’s site.
Company data reported to the SEC on EDGAR (CIK 1035267).
Member research
Everything on ISRG, in full
Every fiscal year and quarter as filed, the filing reader with highlights and AI summaries, insider and fund activity, congressional trades, short interest history, earnings calls, the full price history and every peer. A 7-day free trial, then a subscription.